Gilead ups its donation of the COVID-19 drug remdesivir for U.S. hospitals

Stat News

18 May 2020 - Gilead Sciences, the drug company behind the experimental COVID-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000.

The new number appeared, with no acknowledgement of the shift, in a letter that a U.S. Department of Health and Human Services official sent to governors on Saturday.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Supply , COVID-19